Successfully reported this slideshow.
We use your LinkedIn profile and activity data to personalize ads and to show you more relevant ads. You can change your ad preferences anytime.

Your Vote Matters Cast Your Vote for ATA's President-elect ...


Published on

  • Be the first to comment

  • Be the first to like this

Your Vote Matters Cast Your Vote for ATA's President-elect ...

  1. 1. Your Vote Matters Cast Your Vote for ATA’s President-elect and Directors We encourage you to take part in selecting the president-elect are Gerard M. Doherty, Irwin Klein, Peter Kopp, and and new directors for the ATA Board of Directors by casting Elizabeth N. Pearce. your vote. The ATA Nominating Committee, chaired by Susan Active ATA members will receive a ballot in August and Mandel, brought forth the slate of candidates, which was then are asked to return it by September 15, 2009. Results of the approved by the ATA board of directors. vote will be announced at the ATA membership meeting on Candidates for president-elect are Gregory A. Brent and Thursday, September 24, 2009 at 6:00 pm during the ATA’s 80th Hossein Gharib. The candidates for two director positions Annual Meeting at The Breakers Hotel in Palm Beach, FL. ATA President-elect — Candidate Statements One-year term of office (2009–2010), followed by one-year term as president (2010–2011) and one-year term as a director (past-president, 2011–2012); Vote for One (1) Gregory A. Brent, MD Hossein Gharib, MD Candidate for President-elect Candidate for President-elect Candidate’s Statement Candidate’s Statement I have had the good fortune of being taught The woods are lovely, dark and deep. and mentored by ATA members throughout But I have promises to keep, my training — in medical school (Peter And miles to go before I sleep, Singer, Jorge Mestman), internal medicine residency (Jerome And miles to go before I sleep. Hershman), and endocrinology fellowship (Reed Larsen). These — Robert Frost ATA members nurtured and shaped my interest in the thyroid I am deeply honored to be nominated by the American and my commitment to our association. The ATA has been Thyroid Association (ATA) Board of Directors as a candidate for my professional home and I feel a deep responsibility to give the position of the President-elect of the society. I realize that back to the organization that has been so central in my own the general membership has to approve this and wish to state career development. The ATA welcomes clinicians across many that I am grateful to the ATA leadership for their confidence in disciplines, basic scientists, and clinician scientists, with a shared me. I promise to work hard with enthusiasm and optimism, and interest in the thyroid and its diseases. It is this diversity in our strive to be worthy of your trust. membership and their dedication to the association, that is our As a member of the ATA since 1972, I have regularly attended strength. Since completing my term as Secretary, my focus has annual scientific meetings, served on many ATA committees, and been on our efforts to reach out to fellows and trainees, to recruit am currently on the editorial board of the Thyroid. In 2002, I was and retain our younger members, and to expand our impact in honored with the prestigious Paul Starr Award. promoting basic research. These efforts need to continue. The During my affiliation with the ATA, I have had the privilege of challenge ahead is to sustain our position as the authoritative developing lasting friendships. I have come to know and admire voice in clinical thyroid disease and thyroid research, in the many thyroid specialists with whom I have reviewed thyroid context of limited resources. We need to continue to work issues, argued about politics, discussed personal problems, and with our traditional partners, our sister endocrine societies, the have shared with some of you my own triumphs and tragedies. international thyroid community, thyroid patient groups, and What can I offer the ATA? A loyal member’s dedication, industry. We have a long tradition of leveraging our limited a senior physician’s expertise, and leadership experience as financial resources to expand our impact. In the past several years past-president of AACE. I hope to work closely with the ATA alone we have joined with, the NIH, CDC, FDA, and EPA, in Board and the Administrative Staff to meet the challenges that promoting thyroid research and thyroid health. We can retain the confront us in these uncertain and difficult times. core strengths of the ATA, the collegiality and mutual support I am delighted to be part of this great organization, humbled among the members and meetings of intense interest to clinicians to be nominated for this position, and welcome the opportunity and scientists, yet responsibly sustain and expand our impact in to serve as its next President-elect. However, rest assured that no all aspects of thyroidology. matter what the election outcome, my unwavering support and enthusiasm for the ATA shall remain undisturbed. American Thyroid Association Candidates for President-elect and Directors 2009 Page 1
  2. 2. ATA President-elect — Candidate Biosketches One-year term of office (2009–2010), followed by one-year term as president (2010–2011) and one-year term as a director (past-president, 2011–2012); Vote for One (1) Gregory A. Brent — Biosketch Hossein Gharib — Biosketch Dr. Gregory Brent is Professor of Medicine Dr. Hossein Gharib, a native of Iran, and Physiology, David Geffen School of received his MD degree from the University Medicine at UCLA, and Chief, Endocrinology of Michigan Medical School and completed and Diabetes Division, VA Greater Los his internal medicine and endocrine training Angeles Healthcare System. He was formerly at the Mayo Clinic where he serves as a program director of the VA Greater Los consultant in the Division of Endocrinology, Angeles endocrinology fellowship program (1999–2005). Diabetes, Nutrition, and Metabolism, and is also a Professor Dr. Brent has been a member of the ATA since 1988. He of Medicine at the Mayo Clinic College of Medicine. An has served the ATA as a member of the Patient Education & international authority on thyroid disorders, he has lectured at Advocacy, Membership, Education and Program Committees. over 250 national and international endocrine meetings. He He was Membership Committee Chair, Local Organizing has authored or coauthored more than 250 academic papers, Chair of the 2002 Los Angeles Meeting, Program Co-Chair including peer-reviewed journal articles, guidelines for medical of the 2002 Los Angeles Meeting, and Member of the Board practice, scientific meeting abstracts, and book chapters. of Directors (2000–2007). He has been on the Program Dr. Gharib has served on the editorial boards of JCEM, Committee for the ATA spring multidisciplinary conferences Endocrine Practice, Thyroid, Acta Endocrinologica (Romania), in 2003, 2006, 2007, and 2008. He was Program Co-Director and International Journal of Endocrinology and Metabolism. He of the CDC/ATA conference on pregnancy in 2003, and coedited the first Evidence-Based Endocrinology textbook in the ATA research conferences in 2007 and 2009. He was 2003, with the second edition reprinted in 2008. on the International Coordinating Committee for the 13th He is held in high regard by his peers, and is a Past President International Thyroid Congress in Buenos Aires, Argentina. He of the American Association of Clinical Endocrinologists was Associate Editor of Thyroid (1997–1999). He served as the (AACE) as well as the American College of Endocrinology ATA Secretary/Chief Operating Officer from 2003–2007. He (ACE). He is one of the very few senior physicians honored is currently chair of the ATA Trainee and Career Advancement with a Mastership of both the American College of Physicians Committee (2007–present). (MACP) and the American College of Endocrinology (MACE). Dr. Brent’s research interests include the molecular Dr Gharib is the recipient of numerous awards including mechanisms of thyroid hormone and retinoic acid action, iodine the prestigious Paul Starr Award of the American Thyroid transport in hormone-dependent cancers and thyroid disease in Association (2002), the Laureate Award of the Department of pregnancy. He is a member of the American Society for Clinical Medicine- Mayo Clinic (2004), the International Clinician Investigation and Association of American Physicians. He Award of the Italian Clinical Endocrine Society-AME (2006), recently completed a term as chair of the National Institutes of the Distinction Award of the Brazilian Society of Endocrinology Health, Molecular and Cellular Endocrinology Study Section. He and Metabolism-SBEM (2009), and the Distinguished has been a member of the editorial boards of Thyroid, Molecular Physician Award of the Endocrine Society (2010). Endocrinology and Endocrinology. He was a member of the National Academy of Sciences panel for Assessment of the Health Implications of Perchlorate Ingestion. Dr. Brent has received the Van Meter Prize of the American Thyroid Association, the Knoll Mentor Award from The Endocrine Society, and the Guze Golden Apple Award (2005 and 2009) and Kaiser Excellence in Education Award (2005) from the David Geffen School of Medicine at UCLA. He has been the Samuel F. Hanes Visiting Professor—Mayo Clinic; Sidney Ingbar Visiting Professor— Beth Israel Deaconess Medical Center; and Boris Catz Visiting Professor—Cedars-Sinai Medical Center. Dr. Brent received his undergraduate and medical degree from University of Southern California. He completed his internal medicine residency and chief residency at VA Greater Los Angeles/UCLA. He completed a clinical fellowship in endocrinology at the Brigham and Women’s Hospital and a research fellowship in the Department of Molecular Biology at the Massachusetts General Hospital. American Thyroid Association Candidates for President-elect and Directors 2009 Page 2
  3. 3. ATA Board of Directors — Candidate Statements Four-year term of office (2009–2013); Vote for Two (2) of the four candidates Gerard M. Doherty, MD Peter Kopp, MD Candidate for Director Candidate for Director Candidate’s Statement Candidate’s Statement I believe that the ATA is the critical The ATA plays a preeminent role for intersection for physicians and surgeons professionals and patients through its of different training histories to meet and educational activities, development of exchange scientifically sound experience with thyroid disease. guidelines for clinical care, patient advocacy and public policy My goal as a director of the ATA would be to further engage statements, and support of research. What are the challenges the community of thyroid surgeons to contribute to the ATA, that we have to address? In my view, they include the following. and to expand the perception of the ATA as the definitive Firstly, the ATA has to make ongoing efforts to remain attractive venue for learning about all aspects of care for the thyroid to young investigators and clinicians with a special interest patient. I am proud to emulate two of my mentors in thyroid in thyroid disorders. Our future depends on the integration surgery, Drs. Orlo Clark and Samuel Wells, who have worked and education of the next generation, and providing it with through the ATA to improve thyroid operative care and cancer opportunities to further their career development. Secondly, management strategies. This involvement of surgeons in the efforts to increase funding for thyroid research through the ATA, ATA enhances the society, and improves the quality of surgical the NIH and other sources are crucial for the future of both care by distributing knowledge regarding thyroid disease within basic and clinical thyroid research. Thirdly, the excellent level of the community of interested surgeons. If elected, I pledge educational activities for professionals needs to be maintained, to promote and further develop the ATA as the preeminent several clinical guidelines must be developed or updated, and society for thyroid care by including specialists from all training our efforts to inform and educate patients need increasing backgrounds. attention. Lastly, the collaboration and exchange with other professional societies, nationally and internationally, is essential for maintaining an active voice in public policy, patient advocacy, and aspects of clinical, basic and translational research. I would be honored to help in achieving these goals. Irwin Klein, MD Elizabeth N. Pearce, MD, MSc Candidate for Director Candidate for Director Candidate’s Statement Candidate’s Statement As a Board member, my goals will be to I consider the ATA my home professional maintain the high quality of clinical education society. I value the ATA for its collegiality, its that the ATA provides for all its members. The ability to foster world-class science, and its lifeblood of professional organizations is their ability to enroll mission to educate health professionals and the public about new members. I will strive to maintain the ATA as an attractive thyroid-related issues. I believe it is important for the ATA organization for young clinicians and new investigators and to to reach out to fellows in training and new investigators to promote the field of translational research as a way to enhance foster career development in clinical practice, clinical research, thyroid clinical science. In this most challenging of research and basic science. Expanded fundraising, collaborations with environments, it is my intention to advocate for increased sister societies and patient advocacy groups, and growth of the funding for ATA programs through NIH, industry and private membership base will allow the ATA to continue to thrive, even funding sources. I will also serve as an advocate to improve the in these difficult financial times. environment in which clinical research is conducted through a change in the regulatory hurdles that we all face. American Thyroid Association Candidates for President-elect and Directors 2009 Page 3
  4. 4. ATA Board of Directors — Candidate Biosketches Four-year term of office (2009–2013); Vote for Two (2) of the four candidates Gerard M. Doherty — Biosketch current revision. He has promulgated these guidelines, and Dr. Gerard Doherty, a graduate of the pivotal role of the ATA in thyroid cancer management, in College of the Holy Cross and Yale School of lectures around the world. He has actively brought together Medicine, is currently the Chief of Endocrine surgeons of disparate training backgrounds to work within Surgery and General Surgery at the University the ATA on areas of common interest, including a consensus of Michigan. After training at UCSF and statement regarding central neck dissection, and by promoting the National Cancer Institute, he joined annual meeting program items to attract surgeons to the ATA. Washington University School of Medicine in 1993, and Dr. Doherty’s clinical and research interests focus on endocrine became Professor in 2001 before moving to Ann Arbor in surgical diseases including active basic laboratory research on 2002 as the Norman W. Thompson Professor of Surgery. parathyroid development. His bibliography includes over 250 Dr. Doherty’s active participation in the ATA over the publications and twelve edited textbooks. His current national past decade includes service on the Program Committee and service includes Chair of the NCI Manpower and Training Study the Standards of Care Committee, and the ATA Guidelines Section (reviewing all T32 and K99/R00 applications to the Taskforce. He helped to develop the surgical principles in the NCI) and Secretary-Treasurer of the International Association 2006 “Management Guidelines for Patients with Thyroid of Endocrine Surgeons. He is also Associate Editor of the World Nodules and Differentiated Thyroid Cancer,” as well as their Journal of Surgery and member of several editorial boards. Irwin Klein — Biosketch A member of the ATA since 1982, he has served on the Dr. Irwin Klein is Professor of Medicine Education and Research committees, most recently as the Chair and Cell Biology at NYU School of Medicine of the Research committee. Dr. Klein currently serves on the and Associate Chairman in the Department of trisociety working groups developing clinical practice guidelines Medicine at North Shore University Hospital. in the treatment of hypothyroidism and hyperthyroidism. Dr. Klein is an active clinician, researcher and He was a founding member of the National Thyroid Cancer educator. In addition to his clinical practice Cooperative Treatment Study Group, an active member of the which is directed toward thyroid disease, Dr. Klein maintains American Heart Association Basic Science Council and has been an active basic science research lab focused on thyroid hormone on the editorial boards of Journal of Clinical Endocrinology and effects on the heart and cardiovascular system. His current Metabolism, Endocrinology, Thyroid and Clinical Practice. He investigation is directed at exploring novel thyroid hormone authors the chapters on thyroid disease and heart in Braverman based therapies for heart failure. and Utiger as well as in Braunwald’s “Heart Disease.” Peter Kopp — Biosketch a member of the Website Advisory Committee, and since 2008 Dr. Peter Kopp is an Associate Professor in he is chairing the CME and Guidelines Committee. the Division of Endocrinology, Metabolism Dr. Kopp received his MD degree from the University of and Molecular Medicine, and he serves as Berne, Switzerland in 1985. He completed his training in Internal Director ad interim of the Center for Genetic Medicine and Endocrinology at the same institution. In 1993, he Medicine at the Feinberg School of Medicine joined the Division of Endocrinology at Northwestern University. of Northwestern University in Chicago. Dr. Kopp’s research interests focus primarily on the molecular Dr. Kopp has been an ATA member since 1997. He has been basis of congenital thyroid disorders and thyroid hormone a member of the Program Committee (2002–2005, 2006–2009) synthesis. His clinical activities focus on patients with thyroid and he served as a basic science co-chair for the 78th Annual dysfunction and thyroid cancer, and he is a member of the Meeting in 2007, which was held in New York. In 2006, he was Thyroid Panel of the National Comprehensive Cancer Network. Elizabeth N. Pearce — Biosketch completed her endocrine fellowship and epidemiology training. Dr. Elizabeth Pearce is an Associate Professor She currently chairs the ATA’s Public Health Committee and is a of Medicine at Boston University School of member of the ATA Task Force on Thyroid and Pregnancy. She Medicine in the Section of Endocrinology, co-chaired the 2009 ATA Spring Symposium on Thyroid and Diabetes, and Nutrition. She is also a staff Pregnancy and has delivered invited lectures at many regional, endocrinologist at Harvard Vanguard Medical national, and international meetings. She has previously served on Associates. She is an active clinician, researcher, the ATA Membership and Program Committees, and helps to edit and educator. Her research interests include the sufficiency of the Friends of the ATA online newsletter. She is a member of the Board dietary iodine in the U.S., thyroid function in pregnancy, the of directors of the International Council for the Control of Iodine thyroid effects of environmental perchlorate exposure, and the Deficiency Disorders, and serves as the ATA’s ICCIDD liaison. cardiovascular effects of subclinical thyroid dysfunction. She is also a member of the editorial boards for Thyroid, Endocrine Dr. Pearce has been an ATA member since 2003, when she Practice, and the Journal of Clinical Endocrinology and Metabolism. American Thyroid Association Candidates for President-elect and Directors 2009 Page 4